Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		A Phase II Trial of Bevacizumab (avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)

		Phase:		Phase 2

		Treatment ID#:		1913

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		04/21/2009

		Tumor Types:		Anaplastic Astrocytoma Glioblastoma Multiforme


		Comments:

		Treatment Type:		Chemotherapy

		Contact:		NCI Cheryl Royce, CRNP, Clinical Director National Cancer Institute Neuro-oncology Branch 9030 Old Georgetown Road Bethesda, MD 20892 USA Phone: 866-251-9686 Fax: E-mail: roycec@mail.nih.gov Website: home.ccr.cancer.gov/nob/

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By